![](https://investorshub.advfn.com/uicon/315468.png?cb=1473363790)
Tuesday, September 07, 2021 4:41:07 PM
I have no idea why anyone would be excited about getting current.
The OTCM doesn't place a CE on a company because of delinquent filings - if that was true why wasn't there a CE 2 years ago.
The 52 Week high was $0.0158 - the question becomes how hard will Deitsch pump NPHC.
The patents don't have any value.
The Orphan Drug Designation has no value.
Remember that Deitsch has been pumping NPHC for 19 years - so most investors aren't going to get duped again.
Too many red flags to trade and being long is a very poor investment strategy - some have been holding for 9 years - that was dead money for 9 years.
Deitsch still has too deal with the SEC.
IG
The First Casualty of Emotion is Reason.
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM